ARCHIVES

In Brief: FDA Approves G-CSF For Marketing; Walkmann Wins Belgian Health Prize; Green To Head NWTS

This article is from The Cancer Letter archive.

Vol. 17 No. 09 | March 1, 1991

Download PDF Visit The Full Archive

Related Articles

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

IOM Selects Advisors To Defense Department

February 5, 1993

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

NCAB Approves Funding for New Construction At Georgetown, Yale

June 3, 1977

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996